BRIEF-Coherus BioSciences Q3 Operating Income USD -6.387 Million Vs. IBES Estimate USD -13.3 Million

Reuters11-07
BRIEF-Coherus BioSciences Q3 Operating Income USD -6.387 Million Vs. IBES Estimate USD -13.3 Million

Nov 06 (Reuters) - Coherus BioSciences Q3 net income USD -10.751 million.

  • Q3 pretax profit USD -10.751 million vs. IBES estimate USD -18.6 million
  • Q3 sales USD 70.774 million vs. IBES estimate USD 59.2 million
  • Q3 adjusted net income USD -1.7 million vs. IBES estimate USD -12.1 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment